TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.59B
AUM Growth
-$205M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$42.1M
2
+$23.4M
3
+$21.4M
4
CELG
Celgene Corp
CELG
+$13.2M
5
SAGE
Sage Therapeutics
SAGE
+$11.2M

Top Sells

1
+$25.8M
2
+$23.6M
3
+$21.4M
4
GILD icon
Gilead Sciences
GILD
+$20.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.4M

Sector Composition

1 Healthcare 92.75%
2 Real Estate 2.87%
3 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$26.2M 1.01%
137,968
-81,104
27
$25.2M 0.97%
325,067
-237,400
28
$23.2M 0.9%
460,316
29
$21.4M 0.83%
+349,121
30
$20.7M 0.8%
132,352
31
$20.3M 0.78%
100,002
32
$19.3M 0.75%
123,950
-18,850
33
$19.2M 0.74%
226,460
34
$18.6M 0.72%
334,400
-202,200
35
$16M 0.62%
579,785
+121,169
36
$15.4M 0.59%
167,307
-120,880
37
$15.4M 0.59%
442,600
38
$14.8M 0.57%
24,530
-10,940
39
$14.6M 0.56%
114,966
40
$14.6M 0.56%
543,600
+396,400
41
$13.6M 0.52%
724,606
+173,616
42
$13.4M 0.52%
194,621
43
$13.3M 0.51%
98,421
-175,495
44
$12.9M 0.5%
640,492
+178,780
45
$12.7M 0.49%
287,200
46
$12.4M 0.48%
646,554
47
$12M 0.46%
283,383
+223,729
48
$12M 0.46%
200,000
49
$12M 0.46%
223,700
50
$11.8M 0.46%
858,586
-149,131
1
2
3 4 5